This article is available to subscribers. Subscribe now. Already have an account? Sign in

Medical ProgressFree PreviewArchive

Management of Ovarian Carcinoma — Current Concepts and Future Prospects

List of authors.
  • Jeffrey S. Tobias, M.R.C.P.,
  • and C. Thomas Griffiths, M.D.

ChemotherapyIn view of the unsatisfactory results with operation and radiotherapy in disseminated disease, chemotherapy has been widely employed. The proper evaluation of drug therapy has been hindered by its indiscriminate use after the demonstration, in the early 1950's, that alkylating agents could produce subjective and objective responses.64 65 66 67 Many authors presented their results without defining tumor characteristics or stating whether other therapy was given concurrently or previously. Only a few prospective trials have compared one drug with another or compared chemotherapy with radiation therapy.38, 68 69 70 Chemotherapy with Alkylating AgentsTwo studies evaluating chemotherapy as a surgical adjuvant in localized disease have . . .

Funding and Disclosures

Dr. Tobias is supported by the Cancer Research Campaign (UK) and is Berkeley Travelling Fellow of the University of Cambridge.

We are indebted to Emil Frei, III, M.D., G.P. Canellos, M.D., and Arlan Fuller, Jr., M.D., for criticism and suggestions.

Author Affiliations

From the departments of Medicine and Obstetrics and Gynecology, Harvard Medical School, and the Sidney Farber Cancer Center and Boston Hospital for Women (address reprint requests to Dr. Griffiths at Boston Hospital for Women, 245 Pond Ave., Brookline, MA 02146).

Print Subscriber? Activate your online access.